Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

The FDA has designed five different types of labels, each presenting the same information but with different specifications based on the size of the packaging.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...

BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...

Donald Trump and his advisers are about to launch a consequential battle against unhealthy food producers and the ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...